Tweet
Any one using SeqMonk to do ChIP seq analysis? I found it super easy to use and come with some handy analysis after peak generation, e.g. filter functions. But I don't know what's statistical model behind the peak calling. The program seems not published, so I wonder data generated with this program is acceptable by journals?
-
-
I didn't even know it exists
Looks nice, I'll try ASAP. -
SeqMonk (at least in it's current version) doesn't have a peak detection algorithm as such built in - although you can certainly use the quantitation tools for doing this kind of work.
If your ChIP data is pretty clean with isolated clusters of sequences then you can use the contig probe generator to build probes over clusters of reads. We've used this successfully with traditional ChIP based experiments. The probe generation is not statistically based, but done simply from building contigs of overlapping reads.
For ChIP samples which are much noisier and have reads over much of the genome you're normally better generating tiled probes over the whole genome and then using the window based filters to identify peaks.
For identifying significant enrichments you can either use the distribution based filters or statistical filters such as the boxwhisker filter.
As for why SeqMonk isn't published yet - well it's on my list of stuff to do (but it's far from alone on there!)Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment